Boarding passes or IDs will be replaced by “Touchless ID” technology for United Airlines (UA) passengers traveling through Chicago O’Hare and Los Angeles International airports. The program will continue to roll out across the country. Delta Air Lines (DAL) already has instituted a similar technology at its hubs in Detroit and New York. The Department…
The long saga of the Albertsons (ACI) and Kroger (KR) grocer merger continues as last week the Biden administration announced it is taking legal action to prevent the proposed merger between Kroger and Albertsons supermarket chains, citing concerns that the consolidation would drive up food prices for consumers. Announced by the Federal Trade Commission (FTC)…
On Monday, Seaport Global Securities upgraded its rating on fuboTV (FUBO) shares from Neutral to Buy, with a new price target of $2.50. The move came after the company’s stock initially surged 17% last Friday following strong fourth-quarter 2023 results but later dipped 8% as investor focus shifted back to top-line and subscriber growth. Seaport’s…
After marking its 15th record of the year, the S&P 500 took a step back as investors await crucial job data and Federal Reserve insights. Despite the market’s resilience, caution over a potential consolidation has emerged. Treasury yields rose amid expectations of significant corporate bond offerings, while Federal Reserve Chair Jerome Powell is anticipated to…
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) has received Institutional Review Board (IRB) approval to proceed with its Phase 1 clinical trial of DA-1726 for the treatment of obesity. The company expects to randomize the first patient in Q2 2024. Hyung Heon Kim, President and Chief Executive Officer of NeuroBo, said, “This promising cardiometabolic asset may have…
Here’s your pre-market headline roundup! Super Micro Computer and Deckers Outdoor are set to join the S&P 500, pushing their share prices up by 12% and 5% respectively. They will be replacing Whirlpool and Zion Bancorp, which will move to the S&P MidCap 400 index from March 18. Macy’s shares soared by roughly 17% after…
US stocks received a significant boost this earnings season, led by big tech companies and earnings that exceeded expectations. Despite growing concerns about the economy and uncertainty about Federal Reserve rate cuts, strong corporate results from the final quarter of 2023 underscored the resilience of companies, particularly in the technology sector. Nearly all S&P 500…
Once considered medical curiosities, rare diseases are now recognized for their significant impact on public health. There are 10,000 known rare diseases affecting over 300 million people worldwide, and yet just 5% of these diseases have an approved treatment. The Orphan Drug Act was passed in 1983 to incentivize the development of drugs for rare…
Reddit is set for a significant milestone, aiming for a valuation of up to $6.5 billion in its highly anticipated Initial Public Offering (IPO). Sources close to the situation revealed that the social media giant plans to offer shares priced between $31 and $34 when it lists on the New York Stock Exchange under the…
Here are the firms grabbing the spotlight in today’s midday stock trading: Spirit AeroSystems — The stock witnessed a surge exceeding 12% following indications of Boeing engaging in negotiations with Spirit, with an aim to reacquire the fuselage supplier, almost two decades after becoming an independent entity. Hewlett Packard Enterprise — This tech stock experienced…
Today, both Walgreens Boots Alliance, Inc. (WBA) and CVS Health Corporation (CVS) announced their plans to offer the abortion pill mifepristone in states where it is legally permitted, with implementation slated to commence as early as next week. Walgreens confirmed the completion of the Food and Drug Administration’s certification process for mifepristone sales and anticipates…
Lexaria Bioscience (Nasdaq: LEXX) continues to advance its CBD-based candidate for hypertension with the clearance of its investigational new drug (IND) application by the FDA this week. The company is now planning to initiate a Phase 1b hypertension clinical trial HYPER-H23-1 utilizing DehydraTECH-CBD in the US. Lexaria’s President, John Docherty, commented on the clearance, saying,…